BREAKING: FDA Limits Use of Johnson & Johnson COVID-19 Shot Due to Risk of Blood Clots

BREAKING: FDA Limits Use of Johnson & Johnson COVID-19 Shot Due to Risk of Blood Clots


The U.S. Food and Drug Administration has limited the authorized use of the experimental Johnson & Johnson COVID-19 shot to individuals 18 years of age and older for whom other authorized or approved ‘vaccines’ are not accessible or clinically appropriate due to the risk of a potentially life-threatening side effect.

What is that side effect?

Thrombosis with thrombocytopenia syndrome (TTS), a blood disorder that results in blood clots.

BREAKING REPORT: FDA limits use of Johnson & Johnson Covid-19 vaccine to people 18 and older for whom other authorized or approved vaccines are not accessible or clinically appropriate due to the risk of a rare and potentially life-threatening side effect. -CNBC

Trending: NBC NEWS POLL: 75 Percent Of Americans Think Country Is Headed In The Wrong Direction

— Chuck Callesto (@ChuckCallesto) May 5, 2022

NEW: FDA limits use of

Continue reading

You Might Like

 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Thanks for sharing!
Send this to a friend